Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
I guess the majority of posters to this bb are LTH , with the changes in stock broking systems over the last 10years, if and hoping Sareum announce some fundamentally good news , which moves the share price, it will I am sure be impossible to add to existing holdings ( in any significant volumes) as the technology will lock us out trying to add to our holdings in any meaningful way. In such circumstances it will be easy to sell into a fast moving upward market.
Latest purchase was at full ask at 0.44p
May be Thoth2 gut might be right, news may be on its way soon.
D.
I agree , especially given two factors
1. Sareum and the aim bio sector has a tendancy for share prices to spike upwards significantly on favourable news
2. we can see that only a couple of trades moves the price up or down . Wait till there is news ie a milestone is confirmed or a licence deal this share price will spike significantly, it has done before and i am sure it will again
I am sure Tim and John are working with a clear focuson the end game
My only concern is whether the incentives are correctly balanced. The longer it takes the more significant salaries are paid toTim and John and BOD, and hopefully a better deal licence /t/o ., especially as a lot of their options are underwater at present.
Risk a competitor beats Sareum to the end game or fail in clinical trial .I would like real incentives to be implemented to in essence to speed matters along and reduce the risk by agreeing a license, t/o or even a JV . Interested to see other investors views are
Good luck all LT H
D.
Sierra are up 6% on on over 200,000 shares
traded in the first hour
Perhaps their will be news later this week
which will shortly help Sareum to receive a milestone payment, resulting in a positive rerate.
Wait and see
GLA all LTH
D.
I ask myself has Tim /Sareum been offerred “x “ in principle by a major pharma and turned it down returning with a figure
In the region of “y” for Sareum
X could be any figure say £100m and Y again any figure say £500m
The purpose of my thinking are we anywhere near any deal
Yes we may have had discussions
I guess we must be a long way from a deal as the leaky City of Londons institutional investors are not on the share register
I guess when the II names appears on the share register we might be close to a deal.
Back to my slumber
Wake me in another 2 years
Been invested for 10 years
GLA L T holders
D.
Potnak
My view is Sareum will be subject to a takeover, as as Troth said Sareum are no longer a development co as soon as SDC 1801/2 have been licenced
Tim in my opinion is too old to start further developments and purely from a risk reward view , surely Tim will be looking to sell Sareum as soon as a licence for SDC1801/2 . At the same time . as the licencing deal is concluded , a further payment could be made to acquire the Skil platform. The NADs focus hopefully on acquiring a licence and take over
D.
Interesting to note Sierra have closed up to 0.46 usd with over 840,000 shares trades
It looks to me that some news will be released by Sierra next week
Hope it is aJV , which enables Sierra to fund our milestone payment , which can only help strengthen Sareums share price
Interesting to see the increase in Sierra share price on 1.36m shares traded
Hopefully news will be announced next week that enable sierra to continue to progress and fund SRA737, making the necessary milestone payments to SAR and CRT when they fall due.
D.
Interesting to note that Andrew Allen was appointed to the BOD of Sierra on 25 Oct 2017, He is a key contributor to the advancement of PARP inhibitors.
In February 2019 he purchased USD 108 k of sierra shares at usd 1.64 a share. A reasonable person would think he saw value for money at usd 1.64 a share, and you would assume be aware of future funding plans and strategy for sierra in February and expected a good return from the risks known to the BOD as recently as 4 months ago
D.